Ritchie H, Booth N A
Department of Molecular and Cell Biology, University of Aberdeen, Scotland, UK.
Thromb Haemost. 1998 Apr;79(4):813-7.
Plasminogen activator inhibitor 2 (PAI-2) is produced by activated monocytes in two forms, intracellular and secreted. We have studied the distribution of these two forms in unstimulated human peripheral blood monocytes and after stimulation by thrombin. Fetal calf serum (FCS) in the culture medium was absolutely necessary for accumulation of intracellular PAI-2; but not for synthesis and secretion. Even at a concentration as low as 0.1%, FCS restored accumulation of intracellular PAI-2. Increasing concentrations of FCS resulted in an increase in the ratio of intracellular to secreted PAI-2. The factor that promoted accumulation of intracellular PAI-2 was not a platelet product. Failure of monocytes to accumulate PAI-2 did not reflect leakage due to cell death, as assessed by LDH in culture supernatants. We propose that accumulation of intracellular PAI-2 is not simply due to poor secretion, but is an active process that is modulated by factor(s) found in serum.
纤溶酶原激活物抑制剂2(PAI - 2)由活化的单核细胞以细胞内和分泌两种形式产生。我们研究了这两种形式在未受刺激的人外周血单核细胞以及凝血酶刺激后的分布情况。培养基中的胎牛血清(FCS)对于细胞内PAI - 2的积累是绝对必要的;但对于合成和分泌则不是必需的。即使浓度低至0.1%,FCS也能恢复细胞内PAI - 2的积累。FCS浓度的增加导致细胞内PAI - 2与分泌型PAI - 2的比例增加。促进细胞内PAI - 2积累的因子不是血小板产物。通过培养上清液中的乳酸脱氢酶评估,单核细胞未能积累PAI - 2并不反映由于细胞死亡导致的渗漏。我们提出,细胞内PAI - 2的积累并非仅仅是由于分泌不良,而是一个由血清中发现的因子调节的活跃过程。